Terms: = Leukemia AND MYH9, P35579, 4627, ENSG00000100345, DFNA17 AND Prognosis
3 results:
1. Identification of TLN1 as a prognostic biomarker to effect cell proliferation and differentiation in acute myeloid leukemia.
Cui D; Cui X; Xu X; Zhang W; Yu Y; Gao Y; Mei C; Zheng W
BMC Cancer; 2022 Sep; 22(1):1027. PubMed ID: 36175877
[TBL] [Abstract] [Full Text] [Related]
2. myh9 Facilitates Cell Invasion and Radioresistance in Head and Neck Cancer via Modulation of Cellular ROS Levels by Activating the MAPK-Nrf2-GCLC Pathway.
You GR; Chang JT; Li YL; Huang CW; Tsai YL; Fan KH; Kang CJ; Huang SF; Chang PH; Cheng AJ
Cells; 2022 Sep; 11(18):. PubMed ID: 36139430
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic impact of myh9 expression on patients with acute myeloid leukemia.
Yu M; Wang J; Zhu Z; Hu C; Ma Q; Li X; Yin X; Huang J; Zhang T; Ma Z; Zhou Y; Li C; Chen F; Chen J; Wang Y; Pan H; Wang D; Jin J
Oncotarget; 2017 Jan; 8(1):156-163. PubMed ID: 27437869
[TBL] [Abstract] [Full Text] [Related]
